|
End-of-day quote
Egyptian Exchange
24/09/2026
|
5-day change | 1st Jan Change | ||
| 255.66 EGP | -3.02% |
|
-8.86% | +301.67% |
| 08-13 | GlaxoSmithKline S.A.E Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 05-17 | GlaxoSmithKline Q1 consol net profit EGP 4.7 million | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
Past dividends on GlaxoSmithKline S.A.E
| 12/01/2026 | Annual 1 EGP |
| 18/07/2024 | Annual 0.75 EGP |
| 04/07/2023 | Annual 0.75 EGP |
| 04/01/2023 | Bonus Payment 3 EGP |
| 20/09/2022 | Annual 0.75 EGP |
| 05/07/2021 | Annual 0.5 EGP |
| 01/09/2020 | Annual 0.5 EGP |
| 16/10/2018 | Annual 0.5 EGP |
| 26/12/2017 | Annual 0.5 EGP |
| 15/11/2016 | Annual 0.5 EGP |
| 12/07/2015 | Annual 0.5 EGP |
| 30/06/2014 | Annual 0.75 EGP |
| 04/06/2013 | Annual 0.75 EGP |
| 28/05/2012 | Annual 0.75 EGP |
| 07/06/2011 | Annual 0.75 EGP |
| 27/09/2010 | Annual 0.45 EGP |
| 28/09/2009 | Annual 0.45 EGP |
- Stock Market
- Stocks
- BIOC Stock
- Charts GlaxoSmithKline S.A.E
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
